» Authors » Pinkie Chambers

Pinkie Chambers

Explore the profile of Pinkie Chambers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 67
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
McLean J, Chambers P, Steventon L, Cruickshank S, Nabhani-Gebara S
BMJ Qual Saf . 2025 Feb; PMID: 40000158
Background: Disparities have been identified in many aspects of the cancer care pathway for people from minority ethnic groups (MEGs). Adherence to systemic anticancer therapies (SACTs) has been shown to...
2.
Alarcon Garavito G, Gilchrist K, Ciurtin C, Khanna S, Chambers P, McNally N, et al.
Trials . 2025 Feb; 26(1):65. PMID: 39984940
Background: Clinical trials are essential to the development of healthcare innovations that advance life expectancy and improve quality of life. However, there exists a pronounced disparity in ethnic representation among...
3.
Watson M, Chambers P, Steventon L, Harmsworth King J, Ercia A, Shaw H, et al.
BMJ Oncol . 2025 Jan; 3(1):e000430. PMID: 39886186
Objectives: Routine monitoring of renal and hepatic function during chemotherapy ensures that treatment-related organ damage has not occurred and clearance of subsequent treatment is not hindered; however, frequency and timing...
4.
Abiodun A, Ju C, Welch C, Lai J, Tyrer F, Chambers P, et al.
BMJ Oncol . 2025 Jan; 3(1):e000323. PMID: 39886129
Objective: Fluoropyrimidine chemotherapy is a first-line treatment for many gastrointestinal (GI) cancers, however, cardiotoxicity concerns may limit administration in patients with pre-existing cardiovascular disease (CVD). This study investigated the association...
5.
Watson M, Boulitsakis Logothetis S, Green D, Holland M, Chambers P, Al Moubayed N
BMJ Health Care Inform . 2024 Dec; 31(1). PMID: 39632097
Objectives: Increasing operational pressures on emergency departments (ED) make it imperative to quickly and accurately identify patients requiring urgent clinical intervention. The widespread adoption of electronic health records (EHR) makes...
6.
Mirza L, Steventon L, Roylance R, Hughes C, Creed C, Morris E, et al.
Breast Cancer Res Treat . 2024 Sep; 209(1):139-146. PMID: 39283369
Purpose: Triple-negative breast cancer (TNBC) is an aggressive breast cancer histological type that is predictive of poor outcomes, shorter remission periods and reduced survival. TNBC is treated with surgery and...
7.
Steventon L, Man K, Nicum S, Miller R, Peleg Hasson S, Shah S, et al.
Oncologist . 2024 Sep; 29(11):e1532-e1539. PMID: 39245440
Introduction: Chemotherapy forms the cornerstone of systemic treatment for advanced ovarian cancer, extending overall survival; however, drug-related toxicity can lead to treatment delays, potentially diminishing treatment efficacy. This study evaluated...
8.
Steventon L, Kipps E, Man K, Roylance R, Forster M, Wong I, et al.
Eur J Cancer . 2024 Aug; 210:114301. PMID: 39216173
Background: Inter-cycle delays to chemotherapy are often required to manage drug toxicity. The impact of delays on mortality is poorly characterised. This retrospective cohort study examined the association of treatment...
9.
Ju C, Lau W, Manisty C, Chambers P, Brauer R, Forster M, et al.
ESC Heart Fail . 2024 Jul; 11(6):3911-3923. PMID: 39041459
Aims: We aim to evaluate change in the use of prognostic guideline-directed medical therapies (GDMTs) for heart failure (HF) before and after a cancer diagnosis as well as the matched...
10.
Ju C, Lau W, Chambers P, Man K, Forster M, Mackenzie I, et al.
Pharmacoepidemiol Drug Saf . 2024 Mar; 33(3):e5775. PMID: 38450806
Purpose: A recent observational study suggested statins could reduce cancer diagnosis in patients with heart failure (HF). The findings need to be validated using robust epidemiological methods. This study aimed...